Printer Friendly
The Free Library
14,701,494 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

HAART: no help for the head.


Despite the effectiveness of highly active antiretroviral therapy Noun 1. highly active antiretroviral therapy - a combination of protease inhibitors taken with reverse transcriptase inhibitors; used in treating AIDS and HIV
drug cocktail, HAART
 (HAART HAART highly active antiretroviral therapy.
HAART Highly active antiretroviral therapy, triple combination therapy AIDS The concurrent administration of 2 nucleoside reverse transcriptase inhibitors–eg, AZT and 3TC, and a protease
), the mental health of New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 women with HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  is no better now than it was in pre-HAART years, according to a study comparing two matched samples of infected women, one interviewed in 1994-1996, before the therapy became available, and another in 2000-2002, after its use had become widespread. (1) Mean scores on standard scales measuring depression, self-esteem and mental health were statistically indistinguishable between samples. Likewise, the groups averaged comparable scores on six of seven measures of psychosocial adjustment to chronic illness; the exception was that women in the later sample scored higher than those interviewed in the mid-1990s on a measure related to family life, indicating greater distress. Why the lack of improvement? According to the researchers, women with HIV may experience "multiple chronic stressors" that outweigh any psychological benefit of effective treatments, or they may become demoralized if HAART's effects do not meet their expectations. The researchers urge continued attention to interventions to improve HIV-infected women's mental health and quality of life.

(1.) Siegel K, Karus D and Dean L, Psychosocial characteristics of New York City HIV-infected women before and after the advent of HAART, American Journal of Public Health The American Journal of Public Health (AJPH) is a peer reviewed monthly journal of the American Public Health Association (APHA). The Journal also regularly publishes authoritative editorials and commentaries and serves as a forum for the analysis of health policy. , 2004, 94(7): 1127-1132.
COPYRIGHT 2004 The Alan Guttmacher Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:FYI; Highly active antiretroviral therapy
Author:Hollander, Dore
Publication:Perspectives on Sexual and Reproductive Health
Article Type:Brief Article
Geographic Code:1U2NY
Date:Sep 1, 2004
Words:207
Previous Article:Illegitimate illegitimacy bonuses?(FYI)(Brief Article)
Next Article:Get down with HIV education.(FYI)(Brief Article)
Topics:



Related Articles
"Shy" study suggests new treatment mechanism.
Lactic acidosis during nucleoside antiretroviral HIV therapy.(Letters to the Editor)(Letter to the Editor)
Treatment for HIV and Aids to become a reality.
AIDS-related lymphoma (ARL) presenting as cauda equina syndrome.(Section on Oncology)
MED-15. Management of fluconazole resistant candidal esophagitis in an HIV-infected patient.(Section on Internal Medicine)
Involuntary weight loss: interview with Lisa Capaldini, M.D.(Interview)
Immunology study finds decreased activation markers related to better viral control.
HIV/AIDS research after HAART.(Essays)
Reversible right ventricular dysfunction in HIV-infected patients.(Editorial)
Women & HIV.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles